FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W151947252> ?p ?o ?g. }

• W151947252 abstract "J Clin Psychiatry 2014;75(10):e1185 (doi:10.4088/JCP.14com09351). © Copyright 2014 Physicians Postgraduate Press, Inc. T treatment of depression in patients with bipolar disorder is fundamental to the management and prognosis of this condition. Despite multiple adequately powered, randomized, placebo-controlled studies that demonstrate that antidepressants added to mood stabilizers are no more effective in bipolar illness than placebo,1–3 and are potentially problematic,4,5 the use of antidepressants in patients with bipolar illness remains controversial.6 The confusion derives, in part, from studies showing that antidepressants added to antipsychotics (in type I patients), or used as monotherapy (in type II patients), are effective acutely.7–9 Continued widespread use of antidepressants in bipolar depression10 is probably emblematic of the lack of effective alternatives in a disorder in which depression is the predominant mood.11–13 This unmet need has become fertile ground for a small flowering of innovation in psychiatry. For example, sub–antipsychotic doses of secondgeneration antipsychotics are being repurposed for bipolar depression.14,15 In this issue, Calabrese and colleagues16 present data for another novel option for the treatment of bipolar depression. Armodafinil, and modafinil before it, have been shown in randomized, placebo-controlled studies17 to be safe and effective in the acute treatment of bipolar depression when added to a mood stabilizer. The true value of these studies extends beyond the value of yet another option for depressed patients with bipolar illness. While the mechanisms of action of armodafinil and modafinil are not known, they do not alter serotonin. Rather, they appear to augment signals of dopamine and histamine.18,19 As such, they are the only available prohistamine antidepressant agents used in bipolar illness. Thus, Calabrese and colleagues’ article is introducing a new class of antidepressant treatment for bipolar disorder. Despite the importance of the study, it has clear problems. The effect size was small, and the reason for that is not clear. Armodafinil’s separation from placebo occurred late in the study. It is clear that additional studies are needed to confirm these data and clarify the optimal dose. Furthermore, maintenance studies are required to ensure that the destabilization of the illness that happens with antidepressants does not happen with armodafinil. Ongoing development of these agents, by providing a safe and effective alternative to antidepressants, may ultimately make antidepressant avoidance less controversial in the treatment of bipolar depression. Author affiliations: Mood Disorders Research Program, Depression Center, Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, Kentucky. Potential conflicts of interest: Dr El-Mallakh has received honoraria from AstraZeneca, Otsuka, and Sunovion. Funding/support: None reported." @default.
• W151947252 created "2016-06-24" @default.
• W151947252 creator A5078371495 @default.
• W151947252 date "2014-10-28" @default.
• W151947252 modified "2023-09-27" @default.
• W151947252 title "Innovation in the Treatment of Bipolar Depression" @default.
• W151947252 cites W1965632145 @default.
• W151947252 cites W1972571657 @default.
• W151947252 cites W1989320794 @default.
• W151947252 cites W1994759548 @default.
• W151947252 cites W2014214625 @default.
• W151947252 cites W2028449820 @default.
• W151947252 cites W2044276492 @default.
• W151947252 cites W2085589409 @default.
• W151947252 cites W2093613063 @default.
• W151947252 cites W2107950329 @default.
• W151947252 cites W2111355579 @default.
• W151947252 cites W2111424037 @default.
• W151947252 cites W2114807890 @default.
• W151947252 cites W2128309600 @default.
• W151947252 cites W2129757014 @default.
• W151947252 cites W2161282771 @default.
• W151947252 cites W2166423384 @default.
• W151947252 cites W2317383367 @default.
• W151947252 cites W2467382553 @default.
• W151947252 doi "https://doi.org/10.4088/jcp.14com09351" @default.
• W151947252 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25373127" @default.
• W151947252 hasPublicationYear "2014" @default.
• W151947252 type Work @default.
• W151947252 sameAs 151947252 @default.
• W151947252 citedByCount "0" @default.
• W151947252 crossrefType "journal-article" @default.
• W151947252 hasAuthorship W151947252A5078371495 @default.
• W151947252 hasConcept C118552586 @default.
• W151947252 hasConcept C126322002 @default.
• W151947252 hasConcept C139719470 @default.
• W151947252 hasConcept C142724271 @default.
• W151947252 hasConcept C15744967 @default.
• W151947252 hasConcept C162324750 @default.
• W151947252 hasConcept C168563851 @default.
• W151947252 hasConcept C204787440 @default.
• W151947252 hasConcept C27081682 @default.
• W151947252 hasConcept C2776174506 @default.
• W151947252 hasConcept C2776412080 @default.
• W151947252 hasConcept C2776809841 @default.
• W151947252 hasConcept C2776867660 @default.
• W151947252 hasConcept C2780494398 @default.
• W151947252 hasConcept C2780550438 @default.
• W151947252 hasConcept C2780714222 @default.
• W151947252 hasConcept C2780733359 @default.
• W151947252 hasConcept C2781246090 @default.
• W151947252 hasConcept C71924100 @default.
• W151947252 hasConceptScore W151947252C118552586 @default.
• W151947252 hasConceptScore W151947252C126322002 @default.
• W151947252 hasConceptScore W151947252C139719470 @default.
• W151947252 hasConceptScore W151947252C142724271 @default.
• W151947252 hasConceptScore W151947252C15744967 @default.
• W151947252 hasConceptScore W151947252C162324750 @default.
• W151947252 hasConceptScore W151947252C168563851 @default.
• W151947252 hasConceptScore W151947252C204787440 @default.
• W151947252 hasConceptScore W151947252C27081682 @default.
• W151947252 hasConceptScore W151947252C2776174506 @default.
• W151947252 hasConceptScore W151947252C2776412080 @default.
• W151947252 hasConceptScore W151947252C2776809841 @default.
• W151947252 hasConceptScore W151947252C2776867660 @default.
• W151947252 hasConceptScore W151947252C2780494398 @default.
• W151947252 hasConceptScore W151947252C2780550438 @default.
• W151947252 hasConceptScore W151947252C2780714222 @default.
• W151947252 hasConceptScore W151947252C2780733359 @default.
• W151947252 hasConceptScore W151947252C2781246090 @default.
• W151947252 hasConceptScore W151947252C71924100 @default.
• W151947252 hasLocation W1519472521 @default.
• W151947252 hasLocation W1519472522 @default.
• W151947252 hasOpenAccess W151947252 @default.
• W151947252 hasPrimaryLocation W1519472521 @default.
• W151947252 hasRelatedWork W1801518554 @default.
• W151947252 hasRelatedWork W1964074632 @default.
• W151947252 hasRelatedWork W1967283631 @default.
• W151947252 hasRelatedWork W1974294751 @default.
• W151947252 hasRelatedWork W1989417083 @default.
• W151947252 hasRelatedWork W1997863311 @default.
• W151947252 hasRelatedWork W2016628174 @default.
• W151947252 hasRelatedWork W2035778245 @default.
• W151947252 hasRelatedWork W2061547821 @default.
• W151947252 hasRelatedWork W2064061524 @default.
• W151947252 hasRelatedWork W2065477045 @default.
• W151947252 hasRelatedWork W2072060530 @default.
• W151947252 hasRelatedWork W2075181522 @default.
• W151947252 hasRelatedWork W2080123640 @default.
• W151947252 hasRelatedWork W2086027613 @default.
• W151947252 hasRelatedWork W2191143850 @default.
• W151947252 hasRelatedWork W2724905181 @default.
• W151947252 hasRelatedWork W2803782288 @default.
• W151947252 hasRelatedWork W2902743472 @default.
• W151947252 hasRelatedWork W2947816372 @default.
• W151947252 isParatext "false" @default.
• W151947252 isRetracted "false" @default.
• W151947252 magId "151947252" @default.
• W151947252 workType "article" @default.